Compare products Close window [X]

 
 
  Remove Remove Remove Remove
Apixaban Impurity 86
Furosemide EP Impurity A
Butenafine Impurity 2
Goserelin D7
Title Apixaban Impurity 86 Furosemide EP Impurity A Butenafine Impurity 2 Goserelin D7
Add to cart
Description

Apixaban Impurity 86 is chemically Ethyl (Z)-2-methoxy-2-(2-(4-methoxyphenyl)hydrazono)acetate.
Apixaban Impurity 86 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 86 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Furosemide EP Impurity A is chemically 2-Chloro-4-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid.
It is also known as Furosemide USP Related Compound A ; IsoFurosemide ; Isolasix ; .
Furosemide EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Furosemide EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Furosemide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Butenafine Impurity 2 is chemically N-(4-(Tert-butyl)benzyl)-N-methyl-1-(naphthalen-2-yl)methanamine hydrochloride.
Butenafine Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Butenafine Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Butenafine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Goserelin D7 is chemically (S)-N-((6S,9S,12R,15S,18S,21S,24S)-21-((1H-Indol-3-yl)methyl)-1-amino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazine-1-carbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-25-(1H-imidazol-5-yl)-1-imino-9-(2-(methyl-d3)propyl-2,3,3,3-d4)-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacosan-24-yl)-5-oxopyrrolidine-2-carboxamide.
Goserelin D7 is supplied with detailed characterization data compliant with regulatory guideline. Goserelin D7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Goserelin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Availability In stock In stock In stock In stock
CAS No   4818-59-1 101827-53-6  
Inv. Status Custom Synthesis In Stock In Stock Custom Synthesis
Mol.F. C12H16N2O4 C12H11ClN2O5S C23H27N : HCl C59H77D7N18O14
ISP CAT No ISP-A062121 ISP-F032002 ISP-B088003 ISP-G028D01
Mol.Wt. 252.3 330.7 317.5 : 36.5 1276.5